Global CRM197 Protein Market Research Report 2023

Publication ID:

PB510231383

Publication Date:

October 2, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global CRM197 Protein market is projected to reach US$ 242.4 million in 2029, increasing from US$ 176 million in 2022, with the CAGR of 4.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole CRM197 Protein 91制片厂.
The global CRM197 protein market is expected to continue growing due to the increasing demand for conjugate vaccines and ongoing advancements in vaccine research and development. Adoption of CRM197 in new vaccine formulations, expansion into emerging markets, and collaborations between manufacturers and vaccine developers will contribute to market expansion. Continued investment in research, quality control, and production capacity will support the wider utilization of CRM197 protein in vaccine development efforts worldwide.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global CRM197 Protein market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Pfizer
Fina Biosolutions
Eubiologics
EirGenix Inc.
Xpress Biologics
Ligand Pharmaceuticals
Scarab Genomics
CanSino Biologic
Segment by Type
Research Use
Commercial Use
Segment by Application
Fungal Disease
Viral Disease
Alzheimer's Disease
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The CRM197 Protein report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers鈥� Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers鈥� Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 CRM197 Protein Market Overview
1.1 Product Overview and Scope of CRM197 Protein
1.2 CRM197 Protein Segment by Type
1.2.1 Global CRM197 Protein Market Value Comparison by Type (2023-2029)
1.2.2 Research Use
1.2.3 Commercial Use
1.3 CRM197 Protein Segment by Application
1.3.1 Global CRM197 Protein Market Value by Application: (2023-2029)
1.3.2 Fungal Disease
1.3.3 Viral Disease
1.3.4 Alzheimer's Disease
1.3.5 Other
1.4 Global CRM197 Protein Market Size Estimates and Forecasts
1.4.1 Global CRM197 Protein Revenue 2018-2029
1.4.2 Global CRM197 Protein Sales 2018-2029
1.4.3 Global CRM197 Protein Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 CRM197 Protein Market Competition by Manufacturers
2.1 Global CRM197 Protein Sales Market Share by Manufacturers (2018-2023)
2.2 Global CRM197 Protein Revenue Market Share by Manufacturers (2018-2023)
2.3 Global CRM197 Protein Average Price by Manufacturers (2018-2023)
2.4 Global CRM197 Protein Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of CRM197 Protein, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of CRM197 Protein, Product Type & Application
2.7 CRM197 Protein Market Competitive Situation and Trends
2.7.1 CRM197 Protein Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest CRM197 Protein Players Market Share by Revenue
2.7.3 Global CRM197 Protein Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 CRM197 Protein Retrospective Market Scenario by Region
3.1 Global CRM197 Protein Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global CRM197 Protein Global CRM197 Protein Sales by Region: 2018-2029
3.2.1 Global CRM197 Protein Sales by Region: 2018-2023
3.2.2 Global CRM197 Protein Sales by Region: 2024-2029
3.3 Global CRM197 Protein Global CRM197 Protein Revenue by Region: 2018-2029
3.3.1 Global CRM197 Protein Revenue by Region: 2018-2023
3.3.2 Global CRM197 Protein Revenue by Region: 2024-2029
3.4 North America CRM197 Protein Market Facts & Figures by Country
3.4.1 North America CRM197 Protein Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America CRM197 Protein Sales by Country (2018-2029)
3.4.3 North America CRM197 Protein Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe CRM197 Protein Market Facts & Figures by Country
3.5.1 Europe CRM197 Protein Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe CRM197 Protein Sales by Country (2018-2029)
3.5.3 Europe CRM197 Protein Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific CRM197 Protein Market Facts & Figures by Country
3.6.1 Asia Pacific CRM197 Protein Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific CRM197 Protein Sales by Country (2018-2029)
3.6.3 Asia Pacific CRM197 Protein Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America CRM197 Protein Market Facts & Figures by Country
3.7.1 Latin America CRM197 Protein Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America CRM197 Protein Sales by Country (2018-2029)
3.7.3 Latin America CRM197 Protein Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa CRM197 Protein Market Facts & Figures by Country
3.8.1 Middle East and Africa CRM197 Protein Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa CRM197 Protein Sales by Country (2018-2029)
3.8.3 Middle East and Africa CRM197 Protein Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global CRM197 Protein Sales by Type (2018-2029)
4.1.1 Global CRM197 Protein Sales by Type (2018-2023)
4.1.2 Global CRM197 Protein Sales by Type (2024-2029)
4.1.3 Global CRM197 Protein Sales Market Share by Type (2018-2029)
4.2 Global CRM197 Protein Revenue by Type (2018-2029)
4.2.1 Global CRM197 Protein Revenue by Type (2018-2023)
4.2.2 Global CRM197 Protein Revenue by Type (2024-2029)
4.2.3 Global CRM197 Protein Revenue Market Share by Type (2018-2029)
4.3 Global CRM197 Protein Price by Type (2018-2029)
5 Segment by Application
5.1 Global CRM197 Protein Sales by Application (2018-2029)
5.1.1 Global CRM197 Protein Sales by Application (2018-2023)
5.1.2 Global CRM197 Protein Sales by Application (2024-2029)
5.1.3 Global CRM197 Protein Sales Market Share by Application (2018-2029)
5.2 Global CRM197 Protein Revenue by Application (2018-2029)
5.2.1 Global CRM197 Protein Revenue by Application (2018-2023)
5.2.2 Global CRM197 Protein Revenue by Application (2024-2029)
5.2.3 Global CRM197 Protein Revenue Market Share by Application (2018-2029)
5.3 Global CRM197 Protein Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer CRM197 Protein Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer CRM197 Protein Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Fina Biosolutions
6.2.1 Fina Biosolutions Corporation Information
6.2.2 Fina Biosolutions Description and Business Overview
6.2.3 Fina Biosolutions CRM197 Protein Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Fina Biosolutions CRM197 Protein Product Portfolio
6.2.5 Fina Biosolutions Recent Developments/Updates
6.3 Eubiologics
6.3.1 Eubiologics Corporation Information
6.3.2 Eubiologics Description and Business Overview
6.3.3 Eubiologics CRM197 Protein Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Eubiologics CRM197 Protein Product Portfolio
6.3.5 Eubiologics Recent Developments/Updates
6.4 EirGenix Inc.
6.4.1 EirGenix Inc. Corporation Information
6.4.2 EirGenix Inc. Description and Business Overview
6.4.3 EirGenix Inc. CRM197 Protein Sales, Revenue and Gross Margin (2018-2023)
6.4.4 EirGenix Inc. CRM197 Protein Product Portfolio
6.4.5 EirGenix Inc. Recent Developments/Updates
6.5 Xpress Biologics
6.5.1 Xpress Biologics Corporation Information
6.5.2 Xpress Biologics Description and Business Overview
6.5.3 Xpress Biologics CRM197 Protein Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Xpress Biologics CRM197 Protein Product Portfolio
6.5.5 Xpress Biologics Recent Developments/Updates
6.6 Ligand Pharmaceuticals
6.6.1 Ligand Pharmaceuticals Corporation Information
6.6.2 Ligand Pharmaceuticals Description and Business Overview
6.6.3 Ligand Pharmaceuticals CRM197 Protein Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Ligand Pharmaceuticals CRM197 Protein Product Portfolio
6.6.5 Ligand Pharmaceuticals Recent Developments/Updates
6.7 Scarab Genomics
6.6.1 Scarab Genomics Corporation Information
6.6.2 Scarab Genomics Description and Business Overview
6.6.3 Scarab Genomics CRM197 Protein Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Scarab Genomics CRM197 Protein Product Portfolio
6.7.5 Scarab Genomics Recent Developments/Updates
6.8 CanSino Biologic
6.8.1 CanSino Biologic Corporation Information
6.8.2 CanSino Biologic Description and Business Overview
6.8.3 CanSino Biologic CRM197 Protein Sales, Revenue and Gross Margin (2018-2023)
6.8.4 CanSino Biologic CRM197 Protein Product Portfolio
6.8.5 CanSino Biologic Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 CRM197 Protein Industry Chain Analysis
7.2 CRM197 Protein Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 CRM197 Protein Production Mode & Process
7.4 CRM197 Protein Sales and Marketing
7.4.1 CRM197 Protein Sales Channels
7.4.2 CRM197 Protein Distributors
7.5 CRM197 Protein Customers
8 CRM197 Protein Market Dynamics
8.1 CRM197 Protein Industry Trends
8.2 CRM197 Protein Market Drivers
8.3 CRM197 Protein Market Challenges
8.4 CRM197 Protein Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Pfizer
Fina Biosolutions
Eubiologics
EirGenix Inc.
Xpress Biologics
Ligand Pharmaceuticals
Scarab Genomics
CanSino Biologic

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.